Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place

Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52 patients with coronary heart disease and syst...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: L. I. Olbinskaya, Yu. I. Naymann
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: «SILICEA-POLIGRAF» LLC 2007-02-01
Cyfres:Кардиоваскулярная терапия и профилактика
Pynciau:
chronic heart failure
pulmonary hypertension
endothelin
nebivolol
Mynediad Ar-lein:https://cardiovascular.elpub.ru/jour/article/view/1145
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg